Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition
Respiratory Syncytial Virus (RSV)
Sex
Male or Female
Age
18 - 59 years
Healthy participants
No
Visit ClinicalTrials.gov for more information

Eligibility criteria

Study overview

The purpose of the study is to learn about the immune response after a RSVpreF vaccination. This study is being conducted in Japan. RSV is a common virus that can cause infections of the lungs and airways.

The study is seeking participants who are:

  • 18 to 59 years of age
  • adults with health condition(s) that can put them at an increased risk of severe RSV disease


It will also learn about the safety of RSVpreF vaccination. The study lasts about 2 months. Adults need to visit the research site at least 2 times. The participant will receive a phone call 2 months after vaccination for health checks.

View locations for this study

Find the closest location, your results will be shown below
Find the closest location
    Miles
    0500

    Nearest Locations found

    5 sites found

    Fukuwa Clinic

    Chuo-ku, Tokyo, Japan, 104-0031
    Site Info

    Nihonbashi Sakura Clinic

    Chuo-ku, Tokyo, Japan, 103-0025
    Site Info

    Tenjin Sogo Clinic

    Fukuoka, Japan, 810-0021
    Site Info

    Tokyo-Eki Center-building Clinic

    Chuo-ku, Tokyo, Japan, 103-0027
    Site Info

    Tsuchiura Beryl Clinic

    Tsuchiura, Ibaraki, Japan, 300-0062
    Site Info
    • Recruitment Status
    • Site details
    • Study Contact
    • Clinical Trials ID

    Study Locations

    View locations for this studyFind the closest location, your results will be shown belowFind the closest location